18.08.2015 15:32:00

Moody's: US medical devices outlook brightens on M&A synergies, new products and admission trends

New York, August 18, 2015 -- The US medical products and devices industry will see solid EBITDA growth over the next 12 to 18 months, driven by large M&A deals, new products and an uptick in growth of hospital admissions, says Moody's Investors Service. The rating agency has revised its outlook to positive from stable on the industry.

Vollständigen Artikel bei Moodys lesen